Protagonist Therapeutics, Inc. (Nasdaq: PTGX) ("Protagonist" or "the Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside...

Presentations include initial results for an investigational combination of fianlimab (LAG-3 inhibitor) and Libtayo (PD-1 inhibitor) in advanced non-small cell lung cancer TARRYTOWN, N.Y., Dec. 1,...

Life Time Group Holdings, Inc. ("Life Time" or the "Company") (NYSE: LTH) today announced that the Company is scheduled to participate in a fireside chat discussion at the 2022 Morgan Stanley...

JupiterOne supports AWS Marketplace Vendor Insights feature, AWS joins as member of JupiterOne Stellar Partner Program MORRISVILLE, N.C. and LAS VEGAS, Nov. 30, 2022 /PRNewswire/ -- AWS re:Invent...

Different results for two amyloid-clearing antibody drugs reinforce need to advance robust, diverse pipeline for Alzheimer's disease SAN FRANCISCO, Nov. 30, 2022 /PRNewswire/ -- The phase 3 trial...